Two Dimensions in Targeting HER2 Published 2016-12-02 Download video MP4 360p Recommendations 01:02 Are All Chimeric Antigen Receptors Created Equal? 05:05 Anti-HER2 Mechanisms of Approved HER2 Inhibitors 17:26 Signal Transduction Pathways (G-Protein, Receptor Tyrosine Kinase, cGMP) 40:13 Speak Your Mind Unapologetically with Ivna Curi 06:20 Herceptin signaling pathway | Trastuzumab 03:09 HER2 in Cancer 04:44 The PI3K/AKT signalling pathway 02:06 Trastuzumab Deruxtecan for Breast Cancer | NEJM 07:47 Introduction to Cancer Biology (Part 1): Abnormal Signal Transduction 01:41 The HER Signaling Pathway 04:36 Insulin Signalling Pathway | AKT/PI3k Signalling Pathway 03:37 How Perjeta (Pertuzumab) is Used to Treat HER2-Positive Breast Cancer 03:44 The JAK/STAT pathway 03:12 How PARP inhibitors (PARPi) work 06:01 TGF Beta Signalling Pathway 02:06 EGFR/Ras Pathway Relay Race 07:34 Ras-MAPK pathway | Ras-MAPK in cancer | The MAP Kinase (MAPK) signalling pathway 06:52 Mechanism of Action of Insulin Similar videos 01:41 Targeting HER2 by Combination Therapies 04:33 The HER Pathway and Cancer 00:34 HER2-Targeted Therapies 35:58 HER2 IHC Interpretation Guide (Examples and Challenging Scenarios) 01:13 Challenges to Targeting HER2 in Lung Cancer 57:46 Evolving and Emerging Trends in HER2 Classification and Reporting in Breast Cancer 02:04 Breast Cancer Chess Championship: Trastuzumab vs HER2 Receptor 02:12 Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer | NEJM 05:45 #ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancers 04:52 3-year DFS in randomized trials of chemotherapy and HER2-targeted therapy 02:22 Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer 03:13 HOW DOES TRASTUZUMAB (HERCEPTIN) DOWN-REGULATE HER-2/NEU RECEPTORS 53:12 Stage 4 Breast Cancer - Part 3/4 - "Treatment of stage 4, HER2 positive breast cancers" 04:14 Evo-Ed: Breast Cancer and the HER2 Gene More results